News and Trends 24 Feb 2016
German Biotech wins FDA Approval for New Liver Cancer Trial
4SC, in Germany, has the FDA's green light to conduct efficacy trials in the US with a candidate drug against hepatocellular carcinoma. Munich-based 4SC's lead candidate, resminostat, is a small-molecule being…
